Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesPrevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B
Alimentary Pharmacology and Therapeutics, 11/03/09
Nguyen MH et al. – No rtM204V/I or rtN236T mutations were observed in study. Less than 1% of patients had mutations that can be associated with primary resistance to existing anti–viral therapies for hepatitis B virus.
Related Articles
Hepatitis B does not increase risk for pancreatic cancer
EurekAlert, 11/02/09
Relevance Score: 70%
Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09
Relevance Score: 70%
Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/13/09
Relevance Score: 69%
Entecavir for the long-term treatment of chronic hepatitis B
Expert Review of Anti-infective Therapy, 11/09/09
Relevance Score: 69%
Hepatitis B Virus Resistance to Nucleostide Analogues
Gastroenterology, 10/28/09
Relevance Score: 69%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles
Journal of Viral Hepatitis, 11/25/09
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
Journal of Viral Hepatitis, 11/25/09
Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy
Journal of Viral Hepatitis, 11/25/09
Article Search
Sponsor